Cargando…
A SEMA3 Signaling Pathway-Based Multi-Biomarker for Prediction of Glioma Patient Survival
Glioma is a lethal central nervous system tumor with poor patient survival prognosis. Because of the molecular heterogeneity, it is a challenge to precisely determine the type of the tumor and to choose the most effective treatment. Therefore, novel biomarkers are essential to improve the diagnosis...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582960/ https://www.ncbi.nlm.nih.gov/pubmed/33036421 http://dx.doi.org/10.3390/ijms21197396 |